Log in

CVE:PDPPediapharm Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume26,000 shs
Average Volume100,369 shs
Market CapitalizationC$66.36 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Pediapharm Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-514-7622626

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$11.16 million
Book ValueC($0.01) per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$66.36 million
Next Earnings DateN/A
OptionableOptionable

Receive PDP News and Ratings via Email

Sign-up to receive the latest news and ratings for PDP and its competitors with MarketBeat's FREE daily newsletter.

Pediapharm (CVE:PDP) Frequently Asked Questions

Has Pediapharm been receiving favorable news coverage?

Media headlines about PDP stock have trended very negative this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pediapharm earned a daily sentiment score of -3.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Pediapharm.

Who are some of Pediapharm's key competitors?

What other stocks do shareholders of Pediapharm own?

Who are Pediapharm's key executives?

Pediapharm's management team includes the following people:
  • Mr. Sylvain Chretien, Pres, CEO & Director (Age 54)
  • Mr. Roland Boivin, Chief Financial Officer
  • Mr. Richard Labelle, VP of Sales & Marketing
  • Mr. Benoît Hébert, VP of Bus. Devel. & Licensing (Age 50)
  • Mr. Normand Chartrand, Consultant (Age 59)

What is Pediapharm's stock symbol?

Pediapharm trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PDP."

How do I buy shares of Pediapharm?

Shares of PDP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is Pediapharm?

Pediapharm has a market capitalization of C$0.00 and generates C$11.16 million in revenue each year.

What is Pediapharm's official website?

The official website for Pediapharm is www.pedia-pharm.com.

How can I contact Pediapharm?

Pediapharm's mailing address is 1 du Commerce Pl Suite 225, VERDUN, QC H3E 1A2, Canada. The company can be reached via phone at +1-514-7622626.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.